TulsaLabs to Develop Personalized Health Analytics Utilizing Artificial Intelligence

Rhea-AI Summary

AppSwarm, Corp. (SWRM) has partnered with GTX Corp to develop health analytics using artificial intelligence aimed at enhancing human longevity. This initiative will focus on analyzing health data from wearable devices to identify trends and offer personalized health insights. The cloud-based platform aims to help users adjust their lifestyles, potentially preventing metabolic diseases like diabetes and heart disease. Both companies emphasize the significance of health analytics in light of the COVID pandemic. AppSwarm specializes in software development and mobile app publishing.

Positive

• Partnership with GTX Corp to develop AI-powered health analytics.
• Focus on preventing metabolic diseases like diabetes and heart disease.
• Leveraging data from wearables to provide personalized health insights.

Negative

• None.

Tulsa, OK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- AppSwarm, Corp. (OTC: SWRM), a software development company and aggregator of mobile applications, announced it has been retained by GTX Corp (OTC: GTXO), a pioneer in wearable technology and the health and safety wearable device market, to develop 'health analytics' utilizing artificial intelligence (A.I.) to assist in potentially extending the human life span.

Health data analytics, also known as clinical data analytics, involves the extrapolation of actionable insights from sets of patient data, typically collected from electronic devices, such as wearables. 

Wearables can be employed from different body parts such as head-based, foot-based, eye-based, and wrist-based. Some examples of wearable data include steps taken, food and water intake, calories burned, sleep movement, and breathing. 

TulsaLabs will utilize data generated from wearable devices and sensors to develop cloud-based analytics that will monitor and analyze a user’s health data through long-term dataset development, utilizing artificial intelligence. The A.I. powered platform will then allow users to look for potential trends that can then be offset with lifestyle adjustments to prevent the onset of some of the most common metabolic diseases such as diabetes, heart disease, and obesity. 

"We are very excited at the idea of utilizing artificial intelligence and wearable data to help people live better and even possibly longer lives. Through predictive analytics, users will be able to find the best course of action for health on an individual basis. Developing personalized health data will assist users in avoiding some of the more common causes of metabolic diseases and help increase the quality-of-life for individuals, and society," stated Chris Bailey, the CEO of AppSwarm.

Patrick Bertagna, the CEO of GTX Corp, commented, "One thing COVID has brought to the forefront is how important health is to our longevity, so combining A.I. with wearables will greatly enhance our ability to develop and bring to market powerful health and wellness solutions. We look forward to working with Chris’s team and having them join the longevity revolution with us."

About APPSWARM

AppSwarm is a technology company specializing in accelerated development and publishing of mobile apps and other software platforms for gaming and business applications and seeks to acquire symmetric business opportunities. AppSwarm partners with and assists other development firms in technology development, business management, and funding needs.

For more information, visit us at www.app-swarm.com or follow us on www.facebook.com/AppSwarm Twitter https://twitter.com/AppSwarm or Instagram https://www.instagram.com/appswarm/

“LEGAL DISCLAIMER”

AppSwarm and its affiliate labs are strictly research firms focused on the development of blockchain applications, and in no way is involved with the buying, selling, or the issuance of any cryptocurrencies, or investment advice.

Forward-Looking Statements:

"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking statements that are subject to risk and uncertainties including, but not limited to, the impact of competitive products, product demand, market acceptance risks, fluctuations in operating results, political risk, and other risks detailed from time to time in the Company's filings with OTCMarkets.com and as required to the Securities and Exchange Commission. These risks could cause SWRM's actual results to differ materially from those expressed in any forward-looking statements made by, or on behalf of, the Company.

Investor and Media Contacts:

AppSwarm, Corp.
888-886-8583
info@app-swarm.com

FAQ

What is the recent partnership announced by SWRM?

SWRM has partnered with GTX Corp to develop health analytics using artificial intelligence.

What is the goal of the health analytics project by SWRM?

The goal is to enhance human longevity by analyzing health data from wearable devices.

How will the AI platform developed by SWRM help users?

The AI platform will identify health trends and recommend lifestyle adjustments to prevent metabolic diseases.

What type of diseases is SWRM aiming to prevent with its new project?

SWRM aims to prevent metabolic diseases such as diabetes and heart disease.

What technology is SWRM utilizing in its health analytics project?

SWRM is utilizing artificial intelligence and data from wearable devices.